LungHealth™: The LDCT Lung Cancer Screening Program at BIDMC
Lung cancer is the number-one cancer killer in America, taking more lives than colon, breast and prostate cancer combined. Every year, 200,000 Americans are diagnosed with lung cancer and 160,000 die from it. However, early detection of lung cancer can increase the five-year survival rate for stage 1 lung cancer to nearly 90%.
LungHealth™, the LDCT Lung Cancer Screening Program at BIDMC, provides screening to patients who are at risk for developing lung cancer. Though low-dose computed tomography (CT) examinations, we can proactively and safely screen patients for this disease.
LDCT lung cancer screening is the first and only cost-effective test proven to detect lung cancer at an early stage, which can result in a better chance of survival for patients. LDCT lung cancer screening at BIDMC is performed with a low dose of radiation and has minimal risk for the patient. The LDCT examination does not require the use of contrast and the examination is completed within 10 minutes.
BIDMC is a pioneer in LDCT lung cancer screening and was one of the study sites of the National Lung Cancer Screening Trial, a multi-center trial that was the breakthrough for CT lung cancer screening. Our program also provides an elaborate infrastructure aimed to inform and support our patients and their referring doctors.
Patients eligible LDCT lung cancer for screening:
- Are 55 to 77 years old.
- Have a 30 “pack year” or greater history. (Pack years are calculated using the number of years you smoked and the amount of packs of cigarettes smoked each day. For instance: 1 pack/day for 30 years is 30 pack years; 2 packs/day for 15 years is 30 pack years.)
- Are current or former smokers who have quit in the past 15 years.
- Have no current symptoms of lung cancer such as coughing up blood or sudden weight loss.